XTPL S.A. — Regulatory Filings 2021

Feb 25, 2021

In reference to Current Reports nos. 9/2020, 10/2020 and 11/2020, theManagement Board of XTPL S.A. ("Company", "Issuer"), advises that todaythe Issuer has received another order for the purchase of CL85 nanoinkbased on silver nanoparticles - which is used e.g. for applications inthe LIFT (Laser Induced Forward Transfer) technology - from a WesternEuropean research center conducting research in the nanotechnologysector.

In the opinion of the Company's Management Board, the fact that thebuyer made another order for the nanoink is a confirmation that theproduct is of high quality and meets the customer's requirements.

The Issuer accepted the order, which means that a sales contract wasformed.

The commercial sale of the nanoink to the customer was deemed insideinformation by the Company's Management Board due to the specific natureof the Issuer's business and its understanding by the Company'sshareholders and investors.

At the same time, the key value of the order is that it confirms thecommercialization potential of the Company's proprietary technologies.Acceptance of the product by market buyers, the possibility of obtainingcredentials, and further development of nanoink sales will have apositive influence on the Issuer's operations, cash flows and futurefinancial performance.